Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
amgen
8
×
clinical trials
life sciences
national blog main
biotech
boston blog main
national top stories
new york blog main
boston top stories
new york top stories
fda
inclisiran
new york
regeneron pharmaceuticals
alnylam pharmaceuticals
eli lilly
pcsk9 inhibitors
san francisco blog main
san francisco top stories
sanofi
alirocumab
calcitonin gene-related peptide
cholesterol
chronic migraine
deals
drugs
episodic migraine
evolocumab
indiana blog main
indiana top stories
migraine
national
novartis
pcsk9
praluent
repatha
rna interference
teva pharmaceutical
the medicines co.
abbvie
What
medicines
8
×
drug
fda
new
cholesterol
medco
class
lowering
migraine
announced
approval
approved
developed
nod
pain
starts
twice
won
aces
acquire
adults
agreed
allergan
alnylam
amgen
based
big
billion
bringing
brings
cancer
candidates
cash
ceo
clears
closer
company
compound
data
deal
Language
unset
Current search:
amgen
×
medicines
×
@xconomy.com
4 years ago
Revolution Medicines IPO Reels In $238M to Take On RAS in Cancer
@xconomy.com
4 years ago
Allergan Wins FDA Nod for First Migraine Pill in New Class of Medicines
@xconomy.com
4 years ago
Novartis to Acquire MedCo and FDA-Ready Cholesterol Drug for $9.7B
@xconomy.com
4 years ago
MedCo Preps for FDA Filing as Cholesterol Drug Clears Last Two Tests
@xconomy.com
4 years ago
As Cholesterol Drug Aces Big Test, MedCo CEO Open to Flexible Pricing
@xconomy.com
4 years ago
MedCo Touts New Data for Long-Lasting Heart Drug as Reckoning Looms
@xconomy.com
5 years ago
Eli Lilly Migraine Drug Approved, the Third in New Class of Medicines
@xconomy.com
5 years ago
Amgen Migraine Drug Gets FDA Nod, First in New Class of Medicines